A peptide derived from SARS‐CoV‐2 nucleocapsid protein with broad‐spectrum anti‐coronavirus activity-Reference-Cited by-同舟云学术

A peptide derived from SARS‐CoV‐2 nucleocapsid protein with broad‐spectrum anti‐coronavirus activity

Published:2024-04 Issue:4 Volume:96 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Ye Guoguo¹²,Tang Yimin¹,Yang Qin³,Zhang Chenhui¹²,Shi Huiping⁴,Wang Jun¹,Hu Xiao¹²,Wan Xiaofu¹⁵,Xu Zhixiang¹,Liang Jinhu¹²,Yang Yang¹²,Yang Minghui⁴^ORCID,Liu Yingxia¹²

Affiliation:

1. Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, Division of Infectious Disease, The Third People's Hospital of Shenzhen Second Hospital Affiliated to Southern University of Science and Technology Shenzhen China

2. School of Medicine Southern University of Science and Technology Shenzhen China

3. College of Life Sciences Wuhan University Wuhan China

4. School of Life Science, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Advanced Research Institute of Multidisciplinary Sciences Beijing Institute of Technology Beijing China

5. National Clinical Research Center for Infectious Disease Shenzhen Third People's Hospital Shenzhen Guangdong Province China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.29492

Reference12 articles.

1. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation

2. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates

3. Functional Implications of Intracellular Phase Transitions

4. Advancement in COVID‐19 detection using nanomaterial‐based biosensors

5. Exploration of nanozymes in viral diagnosis and therapy